These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1769371)

  • 1. Membrane stabilising properties of the selective 5-HT2 receptor agonist, (+/-)-DOI.
    Martin KF; Kellett R; Buckett WR
    Eur J Pharmacol; 1991 Jul; 200(1):191-3. PubMed ID: 1769371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
    Pranzatelli MR
    Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI) exerts an anorexic action that is blocked by 5-HT2 antagonists in rats.
    Schechter LE; Simansky KJ
    Psychopharmacology (Berl); 1988; 94(3):342-6. PubMed ID: 3128809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular and cardiac effects of alpha-methyl-5-HT and DOI are mediated by different 5-HT receptors in the pithed rat.
    Chaouche-Teyara K; Fournier B; Safar M; Dabiré H
    Eur J Pharmacol; 1993 Nov; 250(1):67-75. PubMed ID: 7907025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 receptor agonists increase spontaneous sympathetic nerve discharge.
    McCall RB; Harris LT
    Eur J Pharmacol; 1988 Jun; 151(1):113-6. PubMed ID: 3416918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central and peripheral injections of the 5-HT2 agonist, 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, modify cardiovascular function through different mechanisms.
    Dedeoğlu A; Fisher LA
    J Pharmacol Exp Ther; 1991 Dec; 259(3):1027-34. PubMed ID: 1762059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of grayanotoxin-I on threshold intensity and compound action potential of frog sciatic nerve.
    Asçioğlu M; Ozesmi C
    J Physiol Pharmacol; 1996 Jun; 47(2):341-9. PubMed ID: 8807561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle.
    Messori E; Rizzi CA; Candura SM; Lucchelli A; Balestra B; Tonini M
    Br J Pharmacol; 1995 Jun; 115(4):677-83. PubMed ID: 7582490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose- and time-dependent effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a serotonergic 5-HT2 receptor agonist, on local cerebral glucose metabolism in awake rats.
    Freo U; Soncrant TT; Holloway HW; Rapoport SI
    Brain Res; 1991 Feb; 541(1):63-9. PubMed ID: 2029625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE; Berg M; Meyerson BJ
    Eur J Pharmacol; 1993 Oct; 243(2):149-54. PubMed ID: 8276064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5-hydroxytryptamine 5-HT2 receptor antagonists on nerve conduction velocity and endoneurial perfusion in diabetic rats.
    Cameron NE; Cotter MA
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jun; 367(6):607-14. PubMed ID: 12743678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some effects of disopyramide and its N-dealkylated metabolite on isolated nerve and cardiac muscle.
    Grant AM; Marshall RJ; Ankier SI
    Eur J Pharmacol; 1978 Jun; 49(4):389-94. PubMed ID: 668810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of (+/-)-DOI on medial prefrontal cortical cells: a microiontophoretic study.
    Ashby CR; Edwards E; Harkins K; Wang RY
    Brain Res; 1989 Oct; 498(2):393-6. PubMed ID: 2790491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT2/5-HT1C receptor-mediated facilitatory action on unit activity of ventral horn cells in rat spinal cord slices.
    Yamazaki J; Fukuda H; Nagao T; Ono H
    Eur J Pharmacol; 1992 Sep; 220(2-3):237-42. PubMed ID: 1358651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
    Welch JE; Saphier D
    J Pharmacol Exp Ther; 1994 Sep; 270(3):918-28. PubMed ID: 7932204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior.
    Klint T; Dahlgren IL; Larsson K
    Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of the 5-HT2 receptor in the 5-HT receptor-mediated stimulation of prolactin release.
    Albinsson A; Palazidou E; Stephenson J; Andersson G
    Eur J Pharmacol; 1994 Jan; 251(2-3):157-61. PubMed ID: 8149973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists.
    Bagdy G; Sved AF; Murphy DL; Szemeredi K
    Eur J Pharmacol; 1992 Jan; 210(3):285-9. PubMed ID: 1535317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.